Hilmar Sigurdsson

Dr. Hilmar Sigurdsson

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in NeuroImage
Verified
Journal Article
Open access
KDKatherine Dyke
Katherine Dyke
SPSophia E. Pépés
Sophia E. Pépés
CCChen Chen
Chen Chen
SKSoyoung Kim
Soyoung Kim
Hilmar SigurdssonHilmar Sigurdsson
Hilmar Sigurdsson
SJStephen R. Jackson
Stephen R. Jackson
Imbalances in glutamatergic (excitatory) and GABA (inhibitory) signalling within key brain networks are thought to underlie many brain and mental health disorders, and for this reason there is considerable interest in investigating how individual variability in localised concentrations of these molecules relate to brain disorders. Magnetic resonance spectroscopy (MRS) provides a reliable means of measuring, in vivo, concentrations of neurometabolites such as GABA, glutamate and glutamine that can be correlated with brain function and dysfunction. However, an issue of much debate is whether the GABA observed and measured using MRS represents the entire pool of GABA available for measurement (i.e., metabolic, intracellular, and extracellular) or is instead limited to only some portion of it. GABA function can also be investigated indirectly in humans through the use of non-invasive transcranial magnetic stimulation (TMS) techniques that can be used to measure cortical excitability and GABA-mediated physiological inhibition. To investigate this issue further we collected in a single session both types of measurement, i.e., TMS measures of cortical excitability and physiological inhibition and ultra-high-field (7 T) MRS measures of GABA, glutamate and glutamine, from the left sensorimotor cortex of the same group of right-handed individuals. We found that TMS and MRS measures were largely uncorrelated with one another, save for the plateau of the TMS IO curve that was negatively correlated with MRS-Glutamate (Glu) and intra-cortical facilitation (10ms ISI) that was positively associated with MRS-Glutamate concentration. These findings are consistent with the view that the GABA concentrations measured using the MRS largely represent pools of GABA that are linked to tonic rather than phasic inhibition and thus contribute to the inhibitory tone of a brain area rather than GABAergic synaptic transmission.

1 August 2017 in NeuroImage
Verified
Journal Article
Closed access
CCChen Chen
Chen Chen
Hilmar SigurdssonHilmar Sigurdsson
Hilmar Sigurdsson
SPSophia E. Pépés
Sophia E. Pépés
DADorothee P. Auer
Dorothee P. Auer
PMPeter G. Morris
Peter G. Morris
SJStephen R. Jackson
Stephen R. Jackson

1 May 2020 in Cortex
Verified
Journal Article
Closed access
SJStephen R. Jackson
Stephen R. Jackson
JLJoanna Loayza
Joanna Loayza
MCMira Crighton
Mira Crighton
Hilmar SigurdssonHilmar Sigurdsson
Hilmar Sigurdsson
KDKatherine Dyke
Katherine Dyke
GJGeorgina M. Jackson
Georgina M. Jackson

1 June 2020 in Current Biology
Verified
Journal Article
Open access
BMBarbara Morera Maiquez
Barbara Morera Maiquez
Hilmar SigurdssonHilmar Sigurdsson
Hilmar Sigurdsson
KDKatherine Dyke
Katherine Dyke
ECEleri Clarke
Eleri Clarke
PMPolly McGrath
Polly McGrath
SJStephen R. Jackson
Stephen R. Jackson
Tourette syndrome (TS) is a neuropsychiatric disorder characterized by the occurrence of vocal and motor tics. Tics are involuntary, repetitive movements and vocalizations that occur in bouts, typically many times in a single day, and are often preceded by a strong urge-to-tic-referred to as a premonitory urge (PU). TS is associated with the following: dysfunction within cortical-striatal-thalamic-cortical (CSTC) brain circuits implicated in the selection of movements, impaired operation of GABA signaling within the striatum, and hyper-excitability of cortical sensorimotor regions that might contribute to the occurrence of tics. Non-invasive brain stimulation delivered to cortical motor areas can modulate cortical motor excitability, entrain brain oscillations, and reduce tics in TS. However, these techniques are not optimal for treatment outside of the clinic. We investigated whether rhythmic pulses of median nerve stimulation (MNS) could entrain brain oscillations linked to the suppression of movement and influence the initiation of tics in TS. We demonstrate that pulse trains of rhythmic MNS, delivered at 12 Hz, entrain sensorimotor mu-band oscillations, whereas pulse trains of arrhythmic MNS do not. Furthermore, we demonstrate that although rhythmic mu stimulation has statistically significant but small effects on the initiation of volitional movements and no discernable effect on performance of an attentionally demanding cognitive task, it nonetheless leads to a large reduction in tic frequency and tic intensity in individuals with TS. This approach has considerable potential, in our view, to be developed into a therapeutic device suitable for use outside of the clinic to suppress tics and PU in TS.

29 April 2022 in Brain
Verified
Journal Article
Open access
PDF file
NRNicola J Ray
Nicola J Ray
RLRachael A Lawson
Rachael A Lawson
SMSarah L Martin
Sarah L Martin
Hilmar SigurdssonHilmar Sigurdsson
Hilmar Sigurdsson
JWJoanna Wilson
Joanna Wilson
AYAlison J Yarnall
Alison J Yarnall
Free-water imaging can predict and monitor dopamine system degeneration in people with Parkinson’s disease. It can also enhance the sensitivity of traditional diffusion tensor imaging (DTI) metrics for indexing neurodegeneration. However, these tools are yet to be applied to investigate cholinergic system degeneration in Parkinson’s disease, which involves both the pedunculopontine nucleus and cholinergic basal forebrain.Free-water imaging, free-water-corrected DTI and volumetry were used to extract structural metrics from the cholinergic basal forebrain and pedunculopontine nucleus in 99 people with Parkinson’s disease and 46 age-matched controls. Cognitive ability was tracked over 4.5 years.Pearson’s partial correlations revealed that free-water-corrected DTI metrics in the pedunculopontine nucleus were associated with performance on cognitive tasks that required participants to make rapid choices (behavioural flexibility). Volumetric, free-water content and DTI metrics in the cholinergic basal forebrain were elevated in a sub-group of people with Parkinson’s disease with evidence of cognitive impairment, and linear mixed modelling revealed that these metrics were differently associated with current and future changes to cognition.Free water and free-water-corrected DTI can index cholinergic degeneration that could enable stratification of patients in clinical trials of cholinergic interventions for cognitive decline. In addition, degeneration of the pedunculopontine nucleus impairs behavioural flexibility in Parkinson’s disease, which may explain this region’s role in increased risk of falls.

8 September 2021 in Expert Review of Medical Devices
Verified
Journal Article
Open access
Hilmar SigurdssonHilmar Sigurdsson
Hilmar Sigurdsson
RRRachael Raw
Rachael Raw
HHHeather Hunter
Heather Hunter
MBMark Baker
Mark Baker
JTJohn-Paul Taylor
John-Paul Taylor
AYAlison Yarnall
Alison Yarnall
Parkinson’s disease (PD) is a common progressive neurodegenerative disorder with multifactorial etiology. While dopaminergic medication is the standard therapy in PD, it provides limited symptomati...